The health system and startup studio's new joint venture will develop and launch companies that use artificial intelligence to address healthcare problems, including disparities in care. The venture will combine Northwell's clinical expertise and patient data with Aegis' data scientists and commercialization capabilities.
The hedge fund administrator SS&C Technologies Holdings will be the majority stakeholder, while the two payers will each hold a minority interest in the joint venture, dubbed DomaniRx. The company will develop a claims adjudication platform to support its operations.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
The Virginia-based health system is teaming up with BAYADA Home Health Care to create a new company providing home-based and hospice care. BAYADA will oversee the day-to-day operations of the company, while VCU Health will collaborate on overall quality and safety.
The new joint venture will bring K Health's artificial intelligence-driven technology to the consumer, employer and insurer markets. The solution enables patients to understand their symptoms and connect with a doctor if needed.
Mayo Clinic struck joint ventures with two startups to develop and commercialize AI diagnostic tools. It’s part of a broader plan by Mayo Clinic to develop more AI tools to support clinical decisions.
Private equity firm Welsh, Carson, Anderson & Stowe will contribute $600 million to a joint venture with Humana. The funds will be used to develop primary care centers for Medicare patients under Humana’s Partners in Primary Care subsidiary.
3D medical animation services have emerged as a groundbreaking tool in the healthcare industry, revolutionizing the way medical concepts are taught, understood, and marketed.
The potential rewards for drugmakers' investments in pharmaceuticals and vaccines are enormous, but so are the risks, an industry consultant said.
The British drugmaker plans to separate the consumer health joint venture with Pfizer announced Wednesday three years after the transaction closes.